Navigation Links
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
Date:2/27/2008

The Company's effective income tax rate was 18.0 percent and 39.9 percent for the quarters ended December 31, 2007 and 2006, respectively, and 29.7 percent and 38.6 percent for the twelve months ended December 31, 2007 and 2006, respectively. Income tax expense includes federal, state and foreign income tax at statutory rates and the effects of various permanent differences. The decrease in both the quarter and twelve months ended December 31, 2007 effect income tax rate as compared to the comparative periods in 2006 is primarily due to our current estimate of the impact of orphan drug credit for Camvia as well as a $4.0 million benefit for the valuation allowance reduction primarily related to additionally deferred tax assets that management believes are more likely than not to be utilized. Our income tax expense for the years ended December 31, 2007 and 2006 also includes the impact of finalizing the federal and state tax provisions for 2006 and 2005, respectively. We currently anticipate an effective tax rate in the range of approximately 27 percent to 31 percent for the year ended December 31, 2008, which includes an estimate related to orphan drug credit based upon estimates of qualified expenses and excludes the impact of discreet items and any potential changes in the valuation allowance. We continue to evaluate our qualified expenses and, to the extent that actual qualified expenses vary significantly from our estimates, our effective tax rate will be impacted.

Regarding additional payments due to Lilly in connection with the Vancocin acquisition, net sales as of December 31, 2007 exceeded the maximum milestone threshold of $65.0 million. As a result, the Company recorded additional purchase price of $6.0 million to intangible assets in June 2007, which was paid to Lilly in the third quarter.

Working Capital Highlights

As of December 31, 2007, ViroPharma's working capital was $594.4 million, which represents a $328.0 million increase
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. ViroPharma to Present at the Maxim Group First Annual Growth Conference
2. ViroPharma to Present at the UBS Global Life Sciences Conference
3. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
4. ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
5. ViroPharma to Present at the 26th Annual JP Morgan Healthcare Conference
6. ViroPharma Augments Senior Management
7. ViroPharma Provides Update on Vancocin(R)
8. Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
9. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
10. Accuray Incorporated to Report First Quarter Fiscal Year 2008 Financial Results
11. Aflac Incorporated to Release Third Quarter Results On October 23, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... August 30, 2014 In today’s world, ... increasingly difficult to get. Snoring and sleep apnea (a ... breathing stops) robs people and their bed partners of ... Up to 45% of the population snores and 20 ... apnea. Of these, only 10% have been diagnosed and ...
(Date:8/30/2014)... The new review published by Daily Gossip ... Karen Brimeyer, who wanted to make her guide accessible to ... is now easy to find in the form of an ... the author of the new method shares all her tips ... writes in its review that the leaky gut syndrome can ...
(Date:8/30/2014)... 2014 LiveStreamingFitness.com, a company dedicated to providing ... lifestyle resources, is proud to announce it has been recognized ... home fitness solutions by ABC’s Good Morning America. ... ABC’s Good Morning America, “Live Streaming Fitness is the hottest ... day by streamlining your workout…to boot camp at Life Streaming ...
(Date:8/30/2014)... August 30, 2014 When a prominent bank ... as happened on Wednesday, August 27th, when news began surfacing ... JPMorgan Chase & Co and at least one other ... actually investigating attacks on seven prominent banks , everyone ... be affected, and the buzz quickly goes viral. Bloomberg ...
(Date:8/30/2014)... 30, 2014 Final Cut Pro ... the TransGhost plugin from Pixel Film Studios. , “The ... the ability to tell their scary story in a ... Studios. “Users will make their audience scream with this ... With TransGhost users can awaken evil spirits with over ...
Breaking Medicine News(10 mins):Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Leaky Gut Cure Review Reveals Unique Method to Stop Chronic Symptoms 2Health News:LiveStreamingFitness.com is New Trend In Fitness 2Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 2Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 3Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 4Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 5Health News:Pixel Film Studios Released TransGhost Plugin for Final Cut Pro X Today 2Health News:Pixel Film Studios Released TransGhost Plugin for Final Cut Pro X Today 3
... SHANGHAI, China, Oct. 5 ... "the Company"), a leading Chinese firm,specializing in the ... today announced the closing of its,previously announced underwritten ... common stock at $15.00 per share in its ...
... stressed at some point in their life, and there are all ... financial concerns when a 401 (k) loses value, increased workload after ... money woes -- just to name a few. , See video ... easy to get stressed out over stress, but there are two ...
... care units die within 24 hours, but the environment is ... nevertheless happy with the care given, shows a thesis from ... An intensive care unit (ICU) is designed primarily to save ... on an ICU, this often follows a sudden illness or ...
... , ... Blackburn, PhD, 60, of the University of California, San Francisco, today was named to receive ... Greider of Johns Hopkins University School of Medicine and Jack W. Szostak of Harvard Medical ... San Francisco, CA ...
... Calif., Oct. 5 Trapeze Networks, a Belden Brand ... "Trapeze Medical," with the goal of extending the company,s ... Trapeze Medical is focused on three strategies: It ... to the hospitals, clinics and residential care facilities, help ...
... Children in hardest-hit areas remain at risk, warns World Vision ... help children recover , - Aid agency calls on Indonesian ... , PADANG, Indonesia, Oct. 5 As schoolchildren in Indonesia,s ... aid group World Vision says these thousands of children affected ...
Cached Medicine News:Health News:China-Biotics, Inc. Announces Closing of Public Offering of Common Stock 2Health News:China-Biotics, Inc. Announces Closing of Public Offering of Common Stock 3Health News:VIDEO from Medialink and CIGNA: Don't Stress Out Over Stress, Some of it is Good for You 2Health News:Intensive care units poorly equipped to care for the dying 2Health News:UCSF Scientist Receives Nobel Prize in Physiology or Medicine 2Health News:UCSF Scientist Receives Nobel Prize in Physiology or Medicine 3Health News:UCSF Scientist Receives Nobel Prize in Physiology or Medicine 4Health News:Trapeze Networks Announces Trapeze Medical, Bringing Medical-Grade Mobility to Healthcare Market 2Health News:As Schools Reopen in Indonesia, World Vision Says Children's Basic Needs Still Not Being Met 2
(Date:8/29/2014)... Research and Markets has announced the addition ... Pipeline Insight 2014" report to their offering. ... eradicate the prevalence of cancer have achieved limited success ... specificity, safety and large number of side effects, which ... It has been discovered that peptides can be used ...
(Date:8/29/2014)... 2014 According to a ... Extraction type (SFE, Cold Pressed, Organic Solvent, & Others), ... Food Supplements, Fragrance, & Others) - Global Trends & ... segments the Amaranth Seed Oil Market with an ... terms of value. The Amaranth Seed Oil Market ...
(Date:8/29/2014)... Research and Markets has announced ... Forecast of Pharmaceutical Equipment Market in China, 2014-2018" ... Development Trend Forecast of Pharmaceutical Equipment Market in ... China,s pharmaceutical equipment industry in the aspects ... and business performance of domestic major enterprises, as well ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2
... INDIANAPOLIS, Oct. 11, 2011 Eli Lilly and ... due to the December 31 retirements of longtime senior leaders, ... whose Lilly career spans 36 years, has led Lilly Bio-Medicines ... Lilly spans 33 years, has led global manufacturing operations since ...
... 2011 MedPro Imaging, a premium provider of new and ... transducer repair capabilities to include GE E8/E9 transducers.  MedPro is ... probes for the GE E8/E9 ultrasound systems and has been ... care systems for the past six months. In ...
Cached Medicine Technology:Lilly Announces Changes in Senior Management 2Lilly Announces Changes in Senior Management 3Lilly Announces Changes in Senior Management 4MedPro Imaging to Repair GE E8/E9 Ultrasound Transducers 2
... of P.falciparum specific histidine ... specific pLDH and pan malaria ... of P. falciparum and ... other malarial species and for the ...
... a two site sandwich immunoassay ... detection of P. falciparum specific ... and P. vivax specific pLDH. ... used for specific detection and ...
Malaria Pf. Assay Range...
ADVANTAGE MALARIA STIX is a visual, rapid and sensitive immunoassay for the qualitative differential detection of P.falciparum (P.f) and P.vivax (P.v) malaria in Human Blood only....
Medicine Products: